New on the MedlinePlus Drug Safety page:
Joint committee to consider whether 'Low T' products are overprescribed and whether treatment raises heart risks
This email was sent to Email Address. Please click here to unsubscribe from the from the Drug Safety MedlinePlus email list.
Follow MedlinePlus on Twitter 
Search Cloud: See what people are searching for on MedlinePlus
To change your subscription preferences or stop subscriptions anytime, log in to your User Profile with your e-mail address. For questions or problems with this service, please contact subscriberhelp.govdelivery.com.
This is a free service provided by MedlinePlus and the U.S. National Library of Medicine, U.S. Department of Health and Human Services, National Institutes of Health.
